Nature’s Sunshine Products (NASDAQ:NATR) EVP Daniel Norman Sells 8,884 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Daniel Norman sold 8,884 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $20.46, for a total transaction of $181,766.64. Following the completion of the sale, the executive vice president owned 66,636 shares in the company, valued at approximately $1,363,372.56. This trade represents a 11.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Nature’s Sunshine Products Price Performance

NATR stock traded down $0.05 on Thursday, reaching $19.82. 19,524 shares of the company traded hands, compared to its average volume of 79,081. The firm has a fifty day simple moving average of $15.98 and a 200-day simple moving average of $15.50. Nature’s Sunshine Products, Inc. has a one year low of $11.01 and a one year high of $21.64. The company has a market cap of $346.68 million, a P/E ratio of 26.78 and a beta of 1.09.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.18. The firm had revenue of $88.99 million during the quarter, compared to the consensus estimate of $119.39 million. Nature’s Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on NATR. Canaccord Genuity Group boosted their price target on Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. DA Davidson boosted their price objective on shares of Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a report on Monday, November 10th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Nature’s Sunshine Products in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Nature’s Sunshine Products has an average rating of “Moderate Buy” and an average target price of $22.50.

Institutional Investors Weigh In On Nature’s Sunshine Products

Large investors have recently made changes to their positions in the company. Mackenzie Financial Corp purchased a new position in shares of Nature’s Sunshine Products in the first quarter valued at $287,000. Connor Clark & Lunn Investment Management Ltd. raised its stake in Nature’s Sunshine Products by 80.1% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 38,602 shares of the company’s stock worth $484,000 after buying an additional 17,168 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Nature’s Sunshine Products during the 1st quarter worth $437,000. Russell Investments Group Ltd. lifted its position in shares of Nature’s Sunshine Products by 351.2% during the first quarter. Russell Investments Group Ltd. now owns 12,398 shares of the company’s stock valued at $156,000 after buying an additional 9,650 shares during the last quarter. Finally, Jane Street Group LLC purchased a new position in shares of Nature’s Sunshine Products in the 1st quarter worth approximately $174,000. 79.40% of the stock is owned by institutional investors.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.